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Abstract
Since the recent discovery of selenocysteine as the 21st
amino acid in protein, the field of selenium biology has
rapidly expanded. Twelve mammalian selenoproteins
have been characterized to date and each contains selenocysteine that is incorporated in response to specific
UGA code words. These selenoproteins have different
cellular functions, but in those selenoproteins for which
the function is known, selenocysteine is located at the
active center. The presence of selenocysteine at critical
sites in naturally occurring selenoproteins provides an
explanation for the important role of selenium in human
health and development. This review describes known
mammalian selenoproteins and discusses recent developments and future directions in the selenium field.

Selenium is an essential element for many forms of life.
It is a component of naturally occurring selenium-containing proteins and transfer RNAs. In mammals, selenium is covalently bound in all selenoproteins described to
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date as the amino acid selenocysteine (Sec) [48]. In bacterial proteins, selenium also occurs as Sec [49], but in addition this element is present in some selenoproteins as a
dissociable, catalytically essential cofactor [26, 27, 36,
37]. Selenium-containing tRNAs have been detected in
mammals [19] and bacteria [20], but only bacterial seleno-tRNAs have been characterized [98]. The present
review will discuss known selenoproteins in mammals
and future developments in the selenium field. Additional
information on the biology of selenium may be found in
other recent reviews [14, 46, 48, 51, 62, 63, 66, 86].

The Past: The 21st Amino Acid in Protein
The discovery that the code word UGA has a dual
function in the 'almost' universal genetic code [46] marks
the first addition to the code [64] since it was deciphered
[57, 75] and reported to be universal in the mid 1960s
[70]. UGA serves as both a codon for termination of protein synthesis and as a codon for Sec. In this sense, UGA
is analogous to AUG, which functions as both a codon for
initiation of protein synthesis and a codon for methionine
at internal positions of proteins. The role of UGA as a
codon for Sec has been known for about 10 years [64].
However, the fact that Sec is the 21st naturally occurring
amino acid in protein is completely accepted as Sec has its
own tRNA, code word, translation factors and other com-
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ponents involved in the protein translation machinery
[14, 48]. The presence ofa Sec insertion sequence (SECIS)
element downstream of the UGA codon that codes for
this amino acid is necessary for its recognition as a signal
for Sec insertion [66]. Mammalian SECIS elements are
stem-loop structures located in the 3'-untranslated region
of selenoprotein mRNAs [66], while the corresponding
stem-loop structures in bacterial selenoproteins are immediately downstream of the UGA Sec codon [14].
An interesting feature of Sec biosynthesis is that this
amino acid is synthesized on its tRNA. There are many
common steps in Sec biosynthesis in mammalian and
bacterial systems, but the biosynthesis of this amino acid
has only been completely established in prokaryotes [ 14].
Sec tRNA is first aminoacylated with serine, the serine
moiety is in turn modified to an aminoacrylyl intermediate on tRNA in bacterial systems by Sec synthase and
then the intermediate serves as the acceptor for activated
selenium. The selenium donor is selenophosphate which
is synthesized by selenophosphate synthetase [86]. Many
of these steps are apparently very similar in mammals
with the exception that the intermediate in Sec biosynthesis has not been identified and may actually be phosphoseryl-tRNA [47, 48]. In any case, this unique pathway is
highly specific for selenium as sulfur shares many chemical and physical properties with selenium, but sulfur cannot replace selenium in Sec biosynthesis. On the other
hand, selenium can readily substitute for sulfur in sulfur
pathways and be incorporated nonspecifically into proteins in the form of selenomethionine (replacing methionine), Sec (replacing cysteine) and selenium analogs of
sulfur cofactors [reviewed in 48].

The Present:
Selenoproteins, an Even Dozen Thus Far

Twelve mammalian selenoproteins have been described to date which are shown in table 1. They represent
various protein families. Sec is present at the active centers of the characterized selenoenzymes which are the glutathione peroxidases, the iodothyronine deiodinases,
thioredoxin reductase and selenophosphate synthetase.
Although Sec occurs infrequently in protein compared to
other amino acids, its presence at a critical site in these
enzymes suggests that selenium is important for a variety
of biological processes and for human health [63].
A common feature among mammalian selenoproteins
is that they appear to regulate and/or be regulated by intraand/or extracellular redox processes. Nature may have tak-
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en advantage of utilizing Sec at critical sites in certain
enzymes due to the unique redox properties of selenium
[ 16]. Although Sec is structurally similar to cysteine, selenium is a better nucleophile than sulfur and selenocysteines are ionized at physiological pH, while cysteines typically are protonated [48, 86]. The biological function of
several selenoproteins, including selenoprotein P, selenoprotein W and the 15-kd selenoprotein, remains unknown. These proteins, however, contain putative Sec
redox-active centers and it is therefore tempting to speculate that these centers serve a redox-dependent function.

The Glutathione Peroxidase Family
The glutathione peroxidase selenoenzyme family contains four members, GPX1, GPX2, GPX3 and GPX4.
GPX1 is also called classical or cytosolic glutathione peroxidase, GPX2, gastrointestinal glutathione peroxidase,
GPX3, plasma glutathione peroxidase, and GPX4, phospholipid hydroperoxide glutathione peroxidase. GPX1,
GPX2, GPX3 and GPX4 have also been abbreviated as
cGPX, GPX-GI, pGPX and PHGPX, respectively. Glutathione peroxidases are homologous enzymes, which
share several common features such as they catalyze glutathione-dependent degradation of hydroperoxides and
utilize Sec as a critical component of the enzyme active
center. However, each member of this class of selenoenzymes has several distinct characteristics and our current
knowledge of each is summarized below. Additional information on the glutathione peroxidase family of enzymes may be found in the following reviews [2, 22, 48,
88, 93, 94].
(1) Glutathione Peroxidase I (GPX1 or cGPX). GPX1
is one of the most thoroughly studied and best-characterized selenoproteins. It catalyzes glutathione-dependent
reduction of hydrogen peroxide and various organic hydroperoxides. The enzyme is a homotetramer of - 22 kd
subunits and it is located in the cytosol. The genes for
mouse GPXI and Escherichia coli formate dehydrogenase H were the first selenoprotein genes to be sequenced,
which revealed that Sec is encoded by TGA [18, 103].
Bovine erythrocyte GPX1 has been crystallized and its
three-dimensional structure determined [29]. Although
GPX 1 is considered, together with catalase and superoxide dismutase, as a major antioxidant enzyme, its role as
an essential antioxidant has been questioned. Indeed, dramatic losses in GPX1 activity and expression level occur
in selenium-deficient animals [89] without an apparent
effect on cellular metabolism. Such observations led investigators to propose that GPX 1 may serve as a selenium
storage or selenium buffer protein [88]. In addition, when
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Table 1. Mammalian selenocysteine-containing proteins

1

Glutathione peroxidase 1
(GPXt or cGPX)

Glutathione-dependent
hydroperoxide removal

Ubiquitous

h 3q 11-13.1
and/or 3p21.3
m chr. 9

2

Glutathione peroxidase 2
(GPX2 or GPX-GI)

Glutathione-dependent
hydroperoxide removal

Gastrointestinal tract

h 14q24.1
m chr. 12

3

Glutathione peroxidase 3
(GPX3 or pGPX)

Antioxidant
(hydroperoxide removal)

Plasma

h chr. 5
m chr. 11

4

Phospholipid hydroperoxide
glutathione peroxidase
(GPX4 or PHGPX)

Phospholipid hydroperoxide
removal

Ubiquitous

h 19pl 3.3

5

Thyroid hormone deiodinase 1 ( D 1 )

Conversion ofT4 to T3
Inactivation of T3 and T4

Thyroid gland, liver, kidney,
central nervous system

h lp32-p33

6

Thyroid hormone deiodinase 2 ( D 2 )

Conversion ofT4 to T3

Pituitary and thyroid glands,
placenta, heart and skeletal muscles,
central nervous system, brown fat

h 14q24.3

7

Thyroid hormone deiodinase 3 ( D 3 )

Inactivation of T3 and T4

Placenta, central nervous system, skin

h 14q32
m 12F1

8

Thioredoxin reductase (TR1)

NADPH-dependent
reduction of thioredoxin

Ubiquitous

h 12q23-q24.1

9

Selenophosphate synthetase 2 (SPS2)

Synthesisof selenophosphate

Ubiquitous

m chr. 7

10

Selenoprotein P (SelP)

Antioxidant?
Selenium storage?

Plasma

h 5q31

11

Selenoprotein W (SelW)

Redox?

Ubiquitous

h 19q 13.3

12

15-kdselenoprotein

Protein folding?

Ubiquitous

h 1p31

Chromosomal localization is shown for human (h) and mouse (m) selenoprotein genes.

mice lacking the GPX I gene were generated, no phenotypic changes were observed in these knockout mice, even
under hyperoxia conditions [54]. However, recent findings of the essential role of GPX1 in protection of mice
from viral-induced myocarditis suggest that this enzyme
may be important in rescuing cells from environmental
stress [4], while its function under normal conditions may
be compensated for by other cellular components.
Supplementation of the diet with selenium has been
shown to reduce the risk of prostate, colon and lung cancers [23], and chemopreventive properties of this element
have been associated with GPX1. Expression of this

enzyme is often altered in malignant cells relative to controis [30]. Interestingly, GPX1 exhibits contrasting patterns of regulation with another antioxidant selenoenzyme, thioredoxin reductase, in several tested cancer systems [41]. Further research is necessary to determine
which selenoprotein(s) are indeed responsible for chemopreventive properties of selenium.
(2) Glutathione Peroxidase 2 (GPX2 or GPX-GI).
GPX2, like GPX1, is a tetramer consisting of identical
22-kd subunits and occurs in the cytosol. However, in
contrast to GPX1, which is expressed in every cell type
tested, GPX2 is mainly expressed in the epithelium of the
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gastrointestinal tract [22]. In this organ, GPX2 activity
accounts for about 50% of the total selenium-dependent
glutathione peroxidase activity [31 ].
(3) Glutathione Peroxidase 3 (GPX3 or pGPX). GPX3
differs from other glutathione peroxidases in that it is a
glycoprotein and it is the only extracellular selenium-containing glutathione peroxidase. GPX3 is able to detoxify
hydroperoxides in the presence of glutathione. However,
since the levels of glutathione in plasma are extremely
low, an alternative reducing substrate has been sought.
Indeed, it was found that thioredoxin, thioredoxin reductase or glutaredoxin are better electron donors than glutathione for GPX3 under physiological conditions [tl].
These findings are reinforced by the lack of conservation
of the glutathione-binding site in this glutathione peroxidase [94]. The crystal structure at 2.9 A has been recently
reported for GPX3 [81] providing an explanation for differences in substrate specificity and catalytic activities of
plasma and intracellular glutathione peroxidases.

(4) Glutathione Peroxidase 4 (GPX4 or PHGPX).
GPX4 is different from other selenium-dependent glutathione peroxidases in that it is capable of reducing phospholipid hydroperoxides. GPX4 is an - 19-kd monomeric enzyme and it occurs in both a soluble and a membrane-bound form. The subcellular localization of GPX4
is controlled by alternative transcription and translation
sites [78]. Under conditions of limiting selenium, selenium is preferentially incorporated into GPX4 relative to
GPX1. GPX4 is ubiquitously expressed and is one of the
most abundant selenoproteins in mammals (the other
most abundant intracellular selenoproteins are GPX1,
thioredoxin reductase (TR) and the 15-kd selenoprotein).
The dramatic elevation of GPX4 expression in testis after
puberty suggests that this selenoenzyme may have a role
in the male reproductive system [69]. Other selenoproteins may also be involved in mediating an essential role
of selenium in spermatogenesis, particularly testis-specific selenoproteins [87].

The Iodothyronine Deiodinase Family
The iodothyronine deiodinases are a family of three
oxidoreductases that regulate the activity of thyroxine by
catalyzing removal of iodine from the inner (5-iodine) or
outer (Y-iodine) ring of this hormone. Thyroxine is
secreted by the thyroid gland and the deiodinases, designated type 1, type 2 and type 3 deiodinase or D 1, D2 and
D3, are primarily located in mammalian tissues peripherally to the thyroid. Although D1, D2 and D3 have different roles in the activation and inactivation of thyroxine,
these deiodinases share several common features. All

154

J BiomedSci 1999;6:151-160

three are selenoenzymes containing the Sec residue in a
highly homologous sequence that is located in the midregion of each protein. Sec occurs at the enzymes' active
center and is most likely involved in the transfer of iodine.
Each deiodinase is an integral membrane protein and thus
contains, as would be expected, a hydrophobic sequence
in the N-terminal portion of the enzyme. There are several distinct features of D1, D2 and D3 which are discussed
below. It should also be noted that an excellent review on
the deiodinase family has recently been published [62]
and a more detailed account of the substrates, substrate
specificities and primary structures of each deiodinase
may be found in this review.
(5) Type 1 Deiodinase (D1). D 1 is a 29-kd selenoprotein that is capable of deiodinating both the inner and outer ring of the prohormone, T4. Thus, D 1 can convert T4 to
the active hormone, T3, as well as inactivate both T4 and
T3. Its role is to provide T3 to the plasma and to inactivate
T4 and T3. It is located in the thyroid, liver, kidney and
central nervous system and is a thyroid-responsive selenoenzyme.
D 1 occupies a unique historical position in the elucidation of selenoprotein biosynthesis in mammals. The location of the SECIS element in mammalian selenoprotein
mRNA and the role of the SECIS element in determining
that a UGA codon designates Sec instead of termination
was first demonstrated with D1 mRNA [9, 10].
(6) Type 2 Deiodinase (D2). D2 is a 30.5-kd selenoprotein that catalyzes the conversion of T4 to T3. The Km of
D2 for T4 is three orders of magnitude lower than that of
D 1 for T4. This selenoenzyme is essential for providing a
source of T3-receptor-bound T3 in the brain and pituitary
gland. D2 activity may be regulated both pre- and posttranslationally by T4 [see 24 and references therein].
Interestingly, a second TGA codon is encoded in the gene
for rat and human D2 eight codons from the termination
codon that may signal Sec insertion into protein or termination of protein synthesis during transient expression
[24, 85]. D2 is expressed in the pituitary gland, the central
nervous system, placenta and brown fat of humans and
rats and in the thyroid gland and skeletal and heart muscle
of humans, but not rats.
(7) Type 3 Deiodinase (D3). D3 is a 31.5-kd selenoprotein that inactivates T3 and T4 by catalyzing the removal
of iodine from the inner ring of either substrate. D3, like
D 1, is a thyroid-responsive selenoenzyme and it plays the
major role in inactivating T3 or T4. It occurs in placenta,
the central nervous system and skin. D3 is expressed in
highest levels in placenta and functions to impair access
ofT3 and T4 to the fetus.
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(8) Thioredoxin Reductase (TR)
Mammalian TR was first characterized in late 1970s
[56], but it was not until 1996 that this enzyme was recognized as a selenoprotein [38, 91]. Although most selenoproteins contain Sec in the N-terminal portion or in the
middle of the protein, TR contains Sec as a C-terminal
penultimate residue [35, 38, 102], which is essential for
enzyme activity [ 1, 42, 52]. TR is a homodimer consisting
of two identical 55-kd subunits, each containing a ravin
adenine dinucleotide cofactor. The major function of TR
is to catalyze NADPH-dependent reduction of thioredoxin in the cytosol [83]. In addition, TR has been implicated
in a variety of processes, including the reductions ofglutathione peroxidase [11], disulfide isomerase (and related
enzymes) [67, 68], dehydroascorbate [73], ascorbyl-free
radical [74], selenite, selenodiglutathione [13], hydroperoxides [12] and other proteins and compounds. The
broad substrate specificity of TR has been attributed to
the presence of Sec in the enzyme. However, the puzzling
location of Sec in a conserved C-terminal Gly-Cys-SecGly tetrapeptide cannot be explained easily, since other
members of the pyridine nucleotide-disulfide oxidoreductase family, such as glutathione reductase and lipoamide
dehydrogenase, lack the C-terminal See-containing extension [38]. Relative to these other enzymes, TR has three
orders of magnitude higher reactivity to several inhibitory
gold, quinone and alkylating compounds [1, 28, 44, 60,
71, 72, 76, 95]. The high reactivity of TR to these compounds has also been attributed to Sec in the enzyme. The
purified reduced TR can be inactivated by oxygen, while
elevated levels of oxygen in the growth medium resulted
in a lower specific activity of TR. These oxygen-dependent processes have been associated with the loss of selenium from the enzyme [42].
TR is often overexpressed in malignant tissues [34, 38,
41] and it has oncoprotein-like properties [59]. Products
of oncogenes may stimulate cell proliferation and also
sensitize cells to apoptosis [32]. A role of TR and its substrate thioredoxin in cell proliferation [3, 33, 34, 90] and
apoptosis [25, 55, 84] has been reported. In addition, TR
and thioredoxin are involved in redox regulation of cell
signaling [87]. TR occurs in a variety of isoform and
isoenzyme types [38, 42, 61, 82, 87, 91]. We recently discovered and characterized two new mammalian thioredoxin reductases TR2 and TR3 that contain a TGAencoded Sec residue [87]. TR2 is preferentially expressed
in testis, while TR3 contains a mitochondrial targeting
signal and is expressed in various cell types [87].

Mammalian Selenoproteins

(9) Selenophosphate Synthetase 2 (SPS2)
SPS2 is a recently discovered -50-kd selenoenzyme
[45]. It catalyzes activation of selenium in an ATP-dependent manner. The product, which is selenophosphate,
donates selenium to the intermediate in the biosynthesis
of Sec on tRNA. The natural selenoenzyme has not been
isolated, which precluded its detailed characterization,
but the selenide-dependent activity has been demonstrated for the overexpressed cysteine-for-Sec mutant of
SPS2 [58]. SPS2 is homologous to mammalian selenophosphate synthetase 1 (SPS1), with the latter replacing
the putative active center Sec with threonine [65]. Which
of these two selenophosphate synthetases is the major protein involved in selenoprotein synthesis remains to be
determined. Selenophosphate synthetase genes have been
found in bacteria, archaea, Drosophila melanogaster and
Caenorhabditis elegans. These genes encode either Seccontaining or homologous cysteine-containing enzymes.
The finding of Sec in mammalian SPS2 is important in
view of the possible autoregulation mechanism of selenoprotein synthesis, i.e., SPS2 is possibly involved in its own
biosynthesis [45].

(10) Selenoprotein P (Sel P)
Sel P (P designates plasma) is a 57-kd glycoprotein and
is the major selenoprotein in the plasma of mammals [51].
It contains 9-12 Sec residues depending on the organism
in which it occurs and is the only known selenoprotein
that contains more than one Sec residue [80]. All Sec residues in this selenoprotein are coded by UGA. The efficiency of Sec incorporation at each UGA codon in Sel P
mRNA appears to be different which results in multiple
product forms [21] that arise from termination at different UGA codons [53]. In particular, the second in-frame
UGA codon dictates significant termination giving rise to
a selenoprotein product that may have a separate function
[53]. Sel P contains two types of SECIS elements in the
3'-untranslated region of its mRNA suggesting that both
are required for Sec insertion in response to multiple and
different UGA codons [50]. The protein is rapidly expressed following supplementation of selenium-deficient
animals with selenium. It has been suggested that Sel P
serves as an antioxidant [ 17] or selenium storage (or transport) protein. Further studies are required to establish the
function of this interesting selenoprotein.

(I 1) Selenoprotein W (SelW)
SelW is a - 8 - k d intracellular protein of unknown
function [96]. A single Sec residue is present in this protein in an N-terminal putative active center redox motif
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Cys-Gly-Ala-Sec-Gly [97], suggesting the possible involvement of the protein in a redox-related process. The
isolated protein may occur in the glutathionylated form
[8], which is consistent with a putative redox role for
SelW. The protein is expressed in many tissues and in
increased levels in muscle and brain. SelW expression, as
well as expression of most other selenoproteins are regulated by selenium [ 101 ], i.e., selenium elevates selenoprotein expression.

(12) 15-kdSelenoprotein
The 15-kd protein is the most recently discovered selenoprotein. It contains a single Sec residue in the middle of
the protein in a conserved Cys-Gly-Sec-Lys putative redox-active center [39]. The 15-kd protein does not share
any sequence homology to previously characterized proteins and its function currently is not known. The 15-kd
selenoprotein is expressed in a variety of tissues with
increased levels in prostate and thyroid. It has been found
in humans, mice and rats. C. elegans and Brugia malayi
also contain homologs of this selenoprotein, but the homologs have cysteine in place of Sec.
Preliminary evidence suggests that the 15-kd selenoprotein may be involved in cancer [40]. Indeed, selenoprotein expression is altered in several tested cancers and
two cancer-related polymorphisms have been found in the
3'-untranslated region of the human protein, including
one in the SECIS element. These variations in sequence
may potentially affect the expression level of the protein
in malignant relative to normal tissue.
The 15-kd protein has been isolated from rat prostate
and mouse liver in a complex with UDP-glucose glycoprotein glucosyltransferase (UGTR) [40]. Interestingly,
U G T R is involved in quality control of protein folding by
glucosylating misfolded proteins and directing them for
degradation. If indeed the 15-kd protein is involved in
this process, it will be an interesting new role for a selenoprotein.

The Future: Role of Sec in Health and Total
N u m b e r of Selenoproteins

The role that selenium plays as an important component in the diet of mammals apparently changes with age.
That is, selenium serves as an absolutely essential micronutrient in early mammalian development since removal
of the Sec tRNA gene from the mouse genome is lethal to
the embryo [15]. Furthermore, rats that are weaned at
birth onto a selenium-deficient diet manifest dramatically
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slower rates of growth, abnormal muscle and skeletal
development, develop cataracts and a variety of other disorders as compared to their siblings maintained on a selenium-sufficient diet. Adult rats and mice maintained on a
selenium-deficient diet for extended periods of time appear to be less affected by the loss of selenium unless challenged by environmental stress. Although in studies involving selenium-deficient animals, selenoprotein expression has not been reduced as effectively as in Sec tRNA
gene knockout studies, these nutritional experiments suggest that the role of selenium may change from an essential requirement to sustain life in embryonic development
to one that is a requirement for adequate growth and
development at birth to more of a chemopreventive or
protective agent against environmental stress in later life.
Studies involving conditional removal of the Sec tRNA
gene from the genome of mice (i.e., conditional knockouts) at selected stages of development and in selected tissues [5, 77, 79] should provide further insight into defining the role of selenium throughout life. Experiments in
which mice are generated carrying the Sec tRNA gene so
that the gene can be conditionally removed from the
genome of mice are in progress [Hatfield, unpubl, data].
Selenium deficiency in humans is associated with numerous health disorders, including increased cancer risk,
AIDS mortality, heart disease and problems with the male
reproductive system [23, 63, 69]. This may be explained
by the fact that selenium deficiency results in decreased
selenoprotein expression and, hence, in the disruption of
processes that are maintained by these selenoproteins.
Supplementation of the human diet with selenium therefore offers a potentially efficient and inexpensive means
of preventing or delaying the onset of certain of these maladies. Future research will, no doubt, result in determining the precise mechanisms of how selenium benefits
human health and in offering this micronutrient as a
dietary supplement to people at risk of developing various
types of cancer, AIDS and other diseases that are influenced by selenium. Most certainly, many, if not all, of
the beneficial effects of selenium on human health are
mediated by selenoproteins, but which selenoproteins are
involved and their role is not well understood. It is also
quite likely that many protective effects of selenium are
mediated by yet-to-be characterized selenoproteins.
The total number of selenoproteins that are encoded in
the genomes of mammals is difficult to predict. Various
estimates range from 25 to 100. These estimates are based
on 75Se-labeling experiments, which detect selenoprotein
spots on 2D gels [6, 7], and on the extrapolation of the
current proportion of known selenoproteins among all
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characterized proteins taking into account that many selenoproteins are expressed in low levels [Gladyshev, unpubl. data]. In fact, the growing interest in discovering
novel selenoproteins is hampered in part by the difficulty involved in their identification due to low expression
levels.
An important task in further developing the selenoprotein field and in elucidating the role of selenium in human
health is the detection, isolation and characterization of
additional selenoproteins. There are several approaches
that may be used in identifying new selenoproteins. For
example, isolation of labeled proteins from tissues and
cells following labeling of animals and cell lines with 75Se.
Historically, this has been the most productive approach
in identifying new selenoproteins and it still proves to be a
useful technique for this purpose. More recently, identification of Sec-encoded TGA codons and of SECIS elements followed by determination of the selenoprotein
open reading frame in nucleotide databases has been very
useful in finding novel selenoproteins. Searches of databases utilizing the unique features of the Sec insertion
machinery have been aided tremendously by recent developments in projects involving sequencing of entire
genomes, and by the expressed sequence tag projects. For
example, the approach of identifying SECIS elements in
nucleotide databases was recently applied to search for
potential SECIS elements in the HIV genome [43, 92].
SECIS elements are characterized by the presence of a
highly conserved ATGAN[ 10-12 nucleotides]AAN[ 1626 nucleotides]NGAN sequence, which forms stem-loop
structures with AAN located in the loop, and TGAN and
NGAN forming the non-Watson-Crick quartet interac-

tion [66, 99]. Searching for SECIS elements in nucleotide
databases is a unique tool for identifying new mammalian
selenoproteins [Kryukov and Gladyshev, unpubl, data].
An alternative computer approach to search for novel
selenoproteins involves an examination of nucleotide databases for Sec TGA codons. This approach takes advantage of the fact that many mammalian selenoproteins
have homologs in lower eukaryotes, and these homologs
incorporate cysteine in place of Sec. Thus, computer
approaches may be utilized that search for in-frame TGA
codons in the mammalian nucleotide sequences that correspond to TGC/T in lower organisms.
The above approaches of 'digital cloning' for discovering new selenoproteins are unlikely to result in the identification of all mammalian selenoprotein genes, but the
development of these methods will be useful for future
whole genome sequence analyses. Completion of the sequence of the human genome, which is scheduled to be
finished in 2003 [100], as well as completion of the C. elegans and D. melanogaster genome projects will be invaluable in detecting all selenoprotein genes encoded in these
genomes.
An additional area to be explored in the near future is
high-throughput, comprehensive analysis of relative
transcript expression levels [104]. The emerging technologies, such as serial analysis of gene expression, differential display approaches and various hybridization analyses (such as microchips and membranes) will not only
reveal parallel changes in selenoprotein expression, but
also determine how selenium affects expression of proteins that do not contain selenium.
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